IOVA
Iovance BiotherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
IOVA vs peer average
88/100
IOVA vs. peer average (A vs. C)
Grade spread
B 1 · C 5 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Amgen is a loose oncology commercialization comp rather than a direct TIL peer; it is mainly useful as a reminder that scale, payer access, and field execution can separate durable launches from early enthusiasm.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IOVA
Iovance Biotherapeutics
AMGN
Amgen
Grade
A
D
Momentum
84
37
Value
41
64
Sentiment
61
42
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
IOVA / AMGN
Grade Position
Above peers
IOVA vs. peer average (A vs. C)
88/100
Momentum
84
IOVAValue
41
AMGNSentiment
61
IOVARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IOVA
AMGN is the first peer returned for this comparison set.